BMJ 2002;324:705 ( 23 March )

Papers

Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials

John Pickup, professor of diabetes and metabolism, ^a Martin Mattock, senior research fellow, ^b Sally Kerry, lecturer in medical statistics. ^c

^a Department of Chemical Pathology, Metabolic Unit, Guy's, King's, and St Thomas's Hospitals School of Medicine, Guy's Hospital, London SE1 9RT, ^b South West Thames Institute for Renal Research, St Helier Hospital, Carshalton, Surrey SM5 1AA, ^c Department of General Practice and Primary Care, St George's Hospital Medical School, London SW17 0RE

Correspondence to: J Pickup john.pickup{at}kcl.ac.uk

Objective: To compare glycaemic control and insulin dosage in people with type 1 diabetes treated by continuous subcutaneous insulin infusion (insulin infusion pump therapy) or optimised insulin injections.
Design: Meta-analysis of 12 randomised controlled trials.
Participants: 301 people with type 1 diabetes allocated to insulin infusion and 299 allocated to insulin injections for between 2.5 and 24 months.
Main outcome measures: Glycaemic control measured by mean blood glucose concentration and percentage of glycated haemoglobin. Total daily insulin dose.
Results: Mean blood glucose concentration was lower in people receiving continuous subcutaneous insulin infusion compared with those receiving insulin injections (standardised mean difference 0.56, 95% confidence interval 0.35 to 0.77), equivalent to a difference of 1.0 mmol/l. The percentage of glycated haemoglobin was also lower in people receiving insulin infusion (0.44, 0.20 to 0.69), equivalent to a difference of 0.51%. Blood glucose concentrations were less variable during insulin infusion. This improved control during insulin infusion was achieved with an average reduction of 14% in insulin dose (difference in total daily insulin dose 0.58, 0.34 to 0.83), equivalent to 7.58 units/day.
Conclusions: Glycaemic control is better during continuous subcutaneous insulin infusion compared with optimised injection therapy, and less insulin is needed to achieve this level of strict control. The difference in control between the two methods is small but should reduce the risk of microvascular complications.

What is already known on this topic Continuous subcutaneous insulin infusion (insulin pump therapy) produces good long term control of blood glucose concentrations in people with type 1 diabetes Control of blood glucose concentration is substantially better on pump therapy than conventional (non-optimised) injection therapy It is unclear how glycaemic control on pump therapy compares with modern optimised insulin injection regimens What this study adds Though glycaemic control was better during continuous subcutaneous insulin infusion than optimised insulin injection therapy, the difference was relatively small Continuous subcutaneous insulin infusion is an effective form of intensive insulin therapy that should lower the risk of microvascular complications Insulin pump therapy is unnecessary for most people with type 1 diabetes and should be reserved for those with special problems with optimised insulin injections

---

© BMJ 2002
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Insulin pumps are still debatable for type 1 diabetes

J Hans DeVries and Robert J Heine
BMJ 2002 325: 46. [Extract] [Full Text]

Glycaemic control is better with continuous insulin infusion than injections
BMJ 2002 324: 0. [Full Text]

This article has been cited by other articles:

• Logtenberg, S. J., Kleefstra, N., Houweling, S. T., Groenier, K. H., Gans, R. O., van Ballegooie, E., Bilo, H. J. (2009). Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial. Diabetes Care 32: 1372-1377 [Abstract] [Full text]  
• Bolli, G. B., Kerr, D., Thomas, R., Torlone, E., Sola-Gazagnes, A., Vitacolonna, E., Selam, J. L., Home, P. D. (2009). Comparison of a Multiple Daily Insulin Injection Regimen (Basal Once-Daily Glargine Plus Mealtime Lispro) and Continuous Subcutaneous Insulin Infusion (Lispro) in Type 1 Diabetes: A randomized open parallel multicenter study. Diabetes Care 32: 1170-1176 [Abstract] [Full text]  
• Crasto, W, Jarvis, J, Khunti, K, Davies, M J (2009). New insulins and new insulin regimens: a review of their role in improving glycaemic control in patients with diabetes. Postgrad. Med. J. 85: 257-267 [Abstract] [Full text]  
• Ismail, K., Thomas, S. M., Maissi, E., Chalder, T., Schmidt, U., Bartlett, J., Patel, A., Dickens, C. M., Creed, F., Treasure, J. (2008). Motivational Enhancement Therapy with and without Cognitive Behavior Therapy to Treat Type 1 Diabetes: A Randomized Trial. ANN INTERN MED 149: 708-719 [Abstract] [Full text]  
• Ponder, S. W., Skyler, J. S., Kruger, D. F., Matheson, D., Brown, B. W. (2008). Unexplained Hyperglycemia in Continuous Subcutaneous Insulin Infusion: Evaluation and Treatment. The Diabetes Educator 34: 327-333 [Abstract] [Full text]  
• Phillip, M., Battelino, T., Rodriguez, H., Danne, T., Kaufman, F., for the Consensus forum participants, (2007). Use of Insulin Pump Therapy in the Pediatric Age-Group: Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes . Diabetes Care 30: 1653-1662 [Full text]  
• Darby, W. (2006). The Experiences of School Nurses Caring for Students Receiving Continuous Subcutaneous Insulin Infusion Therapy. The Journal of School Nursing 22: 336-344 [Abstract] [Full text]  
• Soliman, A. T., Omar, M., Rizk, M. M., El Awwa, A., AlGhobashy, F. M. (2006). Glycaemic Control with Modified Intensive Insulin Injections (MII) Using Insulin Pens and Premixed Insulin in Children with Type-1 Diabetes: A Randomized Controlled Trial. J Trop Pediatr 52: 276-281 [Abstract] [Full text]  
• Mooradian, A. D., Bernbaum, M., Albert, S. G. (2006). Narrative Review: A Rational Approach to Starting Insulin Therapy. ANN INTERN MED 145: 125-134 [Abstract] [Full text]  
• Nahata, L. (2006). Insulin Therapy in Pediatric Patients with Type I Diabetes: Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections. CLIN PEDIATR 45: 503-508 [Abstract]  
• Yates, K., Hasnat Milton, A., Dear, K., Ambler, G. (2006). Continuous Glucose Monitoring-Guided Insulin Adjustment in Children and Adolescents on Near-Physiological Insulin Regimens: A randomized controlled trial. Diabetes Care 29: 1512-1517 [Abstract] [Full text]  
• Pickup, J. C. (2006). Point: Are Insulin Pumps Underutilized in Type 1 Diabetes? Yes.. Diabetes Care 29: 1449-1452 [Full text]  
• Nimri, R., Weintrob, N., Benzaquen, H., Ofan, R., Fayman, G., Phillip, M. (2006). Insulin pump therapy in youth with type 1 diabetes: a retrospective paired study.. Pediatrics 117: 2126-2131 [Abstract] [Full text]  
• Wilson, D. M., Buckingham, B. A., Kunselman, E. L., Sullivan, M. M., Paguntalan, H. U., Gitelman, S. E. (2005). A Two-Center Randomized Controlled Feasibility Trial of Insulin Pump Therapy in Young Children With Diabetes. Diabetes Care 28: 15-19 [Abstract] [Full text]  
• Weinzimer, S. A., Ahern, J. H., Doyle, E. A., Vincent, M. R., Dziura, J., Steffen, A. T., Tamborlane, W. V. (2004). Persistence of Benefits of Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes: A Follow-up Report. Pediatrics 114: 1601-1605 [Abstract] [Full text]  
• Retnakaran, R., Hochman, J., DeVries, J. H., Hanaire-Broutin, H., Heine, R. J., Melki, V., Zinman, B. (2004). Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections: The impact of baseline A1c. Diabetes Care 27: 2590-2596 [Abstract] [Full text]  
• Bulsara, M. K., Holman, C. D. J., Davis, E. A., Jones, T. W. (2004). The Impact of a Decade of Changing Treatment on Rates of Severe Hypoglycemia in a Population-Based Cohort of Children With Type 1 Diabetes. Diabetes Care 27: 2293-2298 [Abstract] [Full text]  
• Hammond, P. (2004). Continuous subcutaneous insulin infusion: short-term benefits apparent, long-term benefits speculative. British Journal of Diabetes & Vascular Disease 4: 104-108 [Abstract]  
• Torrance, T, Franklin, V, Greene, S (2003). Insulin pumps. Arch. Dis. Child. 88: 949-953 [Full text]  
• DeVries, J. H., Heine, R. J. (2003). Insulin Pump Therapy: a Meta-Analysis: Response to Weissberg-Benchell et al.. Diabetes Care 26: 2485-2485 [Full text]  
• DeWitt, D. E., Hirsch, I. B. (2003). Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review. JAMA 289: 2254-2264 [Abstract] [Full text]  
• Lepore, G., Dodesini, A. R., Nosari, I., Trevisan, R. (2003). Both Continuous Subcutaneous Insulin Infusion and a Multiple Daily Insulin Injection Regimen With Glargine as Basal Insulin Are Equally Better Than Traditional Multiple Daily Insulin Injection Treatment. Diabetes Care 26: 1321-1322 [Full text]  
• Cersosimo, E. (2003). Response to Schade: To pump or not to pump?. Diabetes Care 26: 967-967 [Full text]  
• (2003). OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02). Evid. Based Nurs. 6: e1-1 [Full text]  
• Schade, D. S., Valentine, V. (2002). To Pump or Not to Pump. Diabetes Care 25: 2100-2102 [Full text]  
• (2002). ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB. Evid. Based Med. 7: 131-131 [Full text]  
• DeVries, J H., Heine, R. J (2002). Insulin pumps are still debatable for type 1 diabetes. BMJ 325: 46-46 [Full text]  
• (2002). Continuous Insulin Infusion Provides Better Glycemic Control. JWatch General 2002: 3-3 [Full text]  

Rapid Responses:

Read all Rapid Responses

Please rethink your conclusion

Marisa S. Schmidt
bmj.com, 26 Mar 2002 [Full text]

Hepatic glucose output only controlled with pump

Linda M. Johnson Terner
bmj.com, 26 Mar 2002 [Full text]

People left out of the equation

Elizabeth OShea
bmj.com, 29 Mar 2002 [Full text]

diabetic scientist response

Barbara B. VanRenterghem
bmj.com, 30 Mar 2002 [Full text]

Better glycaemic control with continuous subcutaneous insulin infusion?

J Hans DeVries, et al.
bmj.com, 2 Apr 2002 [Full text]

Walk in the shoes of a parent first

Carol Armstrong
bmj.com, 3 Apr 2002 [Full text]

Meta analysis of the effect of insulin pumps

Dr. Robert M Ehrlich, et al.
bmj.com, 5 Apr 2002 [Full text]

regular or analogue insulin in pumps

Magnus Kollind, et al.
bmj.com, 19 Apr 2002 [Full text]

Think AGAIN

Janice M Vaughan
bmj.com, 2 Aug 2003 [Full text]

Insulin Pumps: Cost-Effective in the UK

Andrew J Palmer, et al.
bmj.com, 6 Oct 2005 [Full text]

Online poll

Find out more on doc2doc >>